Journal Article

Effects of Troglitazone on HepG2 Viability and Mitochondrial Function

Mark A. Tirmenstein, Catherine X. Hu, Tracy L. Gales, Beverly E. Maleeff, Padma K. Narayanan, Edit Kurali, Timothy K. Hart, Heath C. Thomas and Lester W. Schwartz

in Toxicological Sciences

Volume 69, issue 1, pages 131-138
Published in print September 2002 | ISSN: 1096-6080
Published online September 2002 | e-ISSN: 1096-0929 | DOI: http://dx.doi.org/10.1093/toxsci/69.1.131
Effects of Troglitazone on HepG2 Viability and Mitochondrial Function

More Like This

Show all results sharing these subjects:

  • Medical Toxicology
  • Toxicology (Non-medical)

GO

Show Summary Details

Preview

Troglitazone (TRO), a member of the thiazolidinedione class of drugs, has been associated with hepatotoxicity in patients. The following in vitro study was conducted to investigate the effects of TRO on mitochondrial function and viability in a human hepatoma cell line, HepG2. TRO induced a concentration- and time-dependent increase in cell death, as measured by lactate dehydrogenase release. Exposure to 50 or 100 μM TRO produced total loss of cell viability within 5 h. Preincubation of HepG2 cells with P450 inhibitors did not significantly protect against TRO-induced cell death suggesting that P450 metabolism was not required to induce cell death. Preincubation with the mitochondrial permeability transition inhibitor, cyclosporin A, provided complete protection against TRO-induced cell death. Our results also indicated that TRO produced concentration-dependent decreases in cellular ATP levels and mitochondrial membrane potential (MMP). Ultrastructural analysis demonstrated that TRO induced mitochondrial changes at concentrations of ≥10 μM after 2 h. Decreased MMP and altered mitochondrial morphology occurred at time points that preceded cell death and at sublethal concentrations of TRO. These observations in HepG2 cells suggest that TRO disrupts mitochondrial function, leading to mitochondrial permeability transition and cell death.

Keywords: troglitazone; HepG2; hepatotoxicity; mitochondrial permeability transition; cyclosporin A; thiazolidinedione; ATP depletion

Journal Article.  5405 words.  Illustrated.

Subjects: Medical Toxicology ; Toxicology (Non-medical)

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.